| RS587776724 |
PIGA
|
Health Risk |
Pathogenic |
Paroxysmal nocturnal hemoglobinuria, Paroxysmal nocturnal hemoglobinuria |
| RS587776725 |
PIGA
|
Health Risk |
Pathogenic |
Paroxysmal nocturnal hemoglobinuria, Paroxysmal nocturnal hemoglobinuria |
| RS587776726 |
PIGA
|
Health Risk |
Pathogenic |
Paroxysmal nocturnal hemoglobinuria, Paroxysmal nocturnal hemoglobinuria |
| RS587776727 |
PIGA
|
Health Risk |
Pathogenic |
Paroxysmal nocturnal hemoglobinuria, Paroxysmal nocturnal hemoglobinuria |
| RS587776728 |
PIGA
|
Health Risk |
Pathogenic |
Paroxysmal nocturnal hemoglobinuria, Paroxysmal nocturnal hemoglobinuria |
| RS587776729 |
IL2RG
|
Health Risk |
Pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS587776730 |
G6PD
|
Health Risk |
Pathogenic/Likely pathogenic |
Anemia, nonspherocytic hemolytic |
| RS587776731 |
PHKA2
|
Health Risk |
Likely pathogenic |
Glycogen storage disease IXa1, Thyroid cancer |
| RS587776732 |
PHKA2
|
Health Risk |
Pathogenic |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS587776733 |
PHKA2
|
Health Risk |
Pathogenic |
Glycogen storage disease IXa2, Glycogen storage disease IXa2 |
| RS587776734 |
RAB39B
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 72 |
| RS587776735 |
F9
|
Health Risk |
Pathogenic |
Hereditary factor IX deficiency disease, Hereditary factor IX deficiency disease |
| RS587776736 |
F9
|
Health Risk |
Pathogenic |
Hereditary factor IX deficiency disease, Hereditary factor IX deficiency disease |
| RS587776737 |
PORCN
|
Health Risk |
Pathogenic |
Focal dermal hypoplasia, Focal dermal hypoplasia |
| RS587776738 |
AP1S2
|
Health Risk |
Pathogenic |
Pettigrew syndrome, Pettigrew syndrome |
| RS587776739 |
AP1S2
|
Health Risk |
Likely pathogenic |
Pettigrew syndrome, Pettigrew syndrome |
| RS587776740 |
GK
|
Health Risk |
Pathogenic |
Inborn glycerol kinase deficiency, Inborn glycerol kinase deficiency |
| RS587776741 |
TAFAZZIN
|
Health Risk |
Pathogenic |
3-Methylglutaconic aciduria type 2, 3-Methylglutaconic aciduria type 2 |
| RS587776742 |
WAS
|
Health Risk |
Pathogenic |
Wiskott-Aldrich syndrome, Wiskott-Aldrich syndrome |
| RS587776743 |
WAS
|
Health Risk |
Pathogenic |
Wiskott-Aldrich syndrome, Wiskott-Aldrich syndrome |
| RS587776744 |
WAS
|
Health Risk |
Pathogenic |
Wiskott-Aldrich syndrome, Wiskott-Aldrich syndrome |
| RS587776745 |
WAS
|
Health Risk |
Pathogenic |
Wiskott-Aldrich syndrome, X-linked severe congenital neutropenia |
| RS587776746 |
CHM
|
Health Risk |
Pathogenic |
Choroideremia, Retinal dystrophy |
| RS587776747 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Becker muscular dystrophy, Duchenne muscular dystrophy |
| RS587776748 |
TRAPPC2
|
Health Risk |
Pathogenic |
Spondyloepiphyseal dysplasia tarda, Spondyloepiphyseal dysplasia tarda |
| RS587776749 |
TRAPPC2
|
Health Risk |
Pathogenic |
Spondyloepiphyseal dysplasia tarda, Spondyloepiphyseal dysplasia tarda |
| RS587776750 |
TRAPPC2
|
Health Risk |
Pathogenic |
Spondyloepiphyseal dysplasia tarda, Spondyloepiphyseal dysplasia tarda |
| RS587776751 |
TRAPPC2
|
Health Risk |
Pathogenic |
Spondyloepiphyseal dysplasia tarda, Hereditary spastic paraplegia 4 |
| RS587776752 |
TRAPPC2
|
Health Risk |
Pathogenic |
Spondyloepiphyseal dysplasia tarda, X-linked |
| RS587776753 |
TRAPPC2
|
Health Risk |
Pathogenic |
Spondyloepiphyseal dysplasia tarda, Spondyloepiphyseal dysplasia tarda |
| RS587776754 |
TRAPPC2
|
Health Risk |
Pathogenic |
Spondyloepiphyseal dysplasia tarda, Spondyloepiphyseal dysplasia tarda |
| RS587776755 |
RPS6KA3
|
Health Risk |
Pathogenic |
Coffin-Lowry syndrome, Coffin-Lowry syndrome |
| RS587776756 |
ATRX
|
Health Risk |
Pathogenic |
Acquired hemoglobin H disease, Acquired hemoglobin H disease |
| RS587776757 |
G6PC1
|
Health Risk |
Pathogenic |
Glycogen storage disease due to glucose-6-phosphatase deficiency type IA, Glycogen storage disease due to glucose-6-phosphatase deficiency type IA |
| RS587776758 |
PCCB
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS587776759 |
SLC25A20
|
Health Risk |
Pathogenic |
Carnitine acylcarnitine translocase deficiency, Carnitine acylcarnitine translocase deficiency |
| RS587776760 |
SLC25A20
|
Health Risk |
Pathogenic |
Carnitine acylcarnitine translocase deficiency, Carnitine acylcarnitine translocase deficiency |
| RS587776761 |
UGT1A1
|
Health Risk |
Pathogenic |
Crigler-Najjar syndrome type 1, Crigler-Najjar syndrome type 1 |
| RS587776762 |
UGT1A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Crigler-Najjar syndrome type 1, Crigler-Najjar syndrome |
| RS587776763 |
UGT1A1
|
Health Risk |
Pathogenic |
Crigler-Najjar syndrome type 1, Crigler-Najjar syndrome type 1 |
| RS587776764 |
UGT1A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Crigler-Najjar syndrome type 1, Crigler-Najjar syndrome |
| RS587776765 |
UGT1A1
|
Health Risk |
Likely pathogenic |
Crigler-Najjar syndrome type 1, Crigler-Najjar syndrome |
| RS587776766 |
UGT1A1
|
Health Risk |
Pathogenic |
Crigler-Najjar syndrome type 1, Crigler-Najjar syndrome type 1 |
| RS587776767 |
TH
|
Health Risk |
Pathogenic |
Autosomal recessive DOPA responsive dystonia, Autosomal recessive DOPA responsive dystonia |
| RS587776768 |
TP53
|
Health Risk |
Pathogenic |
Li-Fraumeni syndrome 1, Li-Fraumeni syndrome 1 |
| RS587776769 |
TGFBR2
|
Health Risk |
Pathogenic |
Colorectal cancer, hereditary nonpolyposis |
| RS587776770 |
TGFBR2
|
Health Risk |
Likely pathogenic |
Loeys-Dietz syndrome 2, Loeys-Dietz syndrome 2 |
| RS587776771 |
HNF1B
|
Health Risk |
Pathogenic |
Chromophobe renal cell carcinoma, Renal cysts and diabetes syndrome |
| RS587776772 |
TTN
|
Health Risk |
Pathogenic |
Early-onset myopathy with fatal cardiomyopathy, Early-onset myopathy with fatal cardiomyopathy |
| RS587776773 |
PRKAR1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Pigmented nodular adrenocortical disease, primary |
| RS587776774 |
PRKAR1A
|
Health Risk |
Pathogenic |
Adrenocortical tumor, somatic |
| RS587776776 |
SOX2
|
Health Risk |
Pathogenic |
Anophthalmia/microphthalmia-esophageal atresia syndrome, Anophthalmia/microphthalmia-esophageal atresia syndrome |
| RS587776777 |
SPR
|
Health Risk |
Pathogenic |
Dopa-responsive dystonia due to sepiapterin reductase deficiency, Dopa-responsive dystonia due to sepiapterin reductase deficiency |
| RS587776778 |
SAG
|
Health Risk |
Pathogenic |
Oguchi disease, Retinitis pigmentosa 47 |
| RS587776779 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS587776780 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS587776781 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS587776782 |
RB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS587776783 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS587776784 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS587776785 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS587776786 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS587776787 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS587776788 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS587776789 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS587776790 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS587776791 |
RB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinoblastoma, Retinoblastoma |
| RS587776793 |
PDGFRA
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Gastrointestinal stromal tumor |
| RS587776794 |
PDGFRA
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Gastrointestinal stromal tumor |
| RS587776795 |
PDGFRA
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Gastrointestinal stromal tumor |
| RS587776797 |
ENPP1
|
Health Risk |
Pathogenic |
Hypophosphatemic rickets, autosomal recessive |
| RS587776798 |
POU1F1
|
Health Risk |
Likely pathogenic |
Pituitary hormone deficiency, combined |
| RS587776799 |
POU1F1
|
Health Risk |
Pathogenic |
Pituitary hormone deficiency, combined |
| RS587776800 |
PLA2G2A
|
Health Risk |
Pathogenic |
Familial colorectal cancer, Familial colorectal cancer |
| RS587776801 |
PGM1
|
Health Risk |
Pathogenic |
PGM1-congenital disorder of glycosylation, PGM1-congenital disorder of glycosylation |
| RS587776802 |
PIK3CA
|
Health Risk |
Likely pathogenic |
Hepatocellular carcinoma, Gastric cancer |
| RS587776804 |
KIT
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Gastrointestinal stromal tumor |
| RS587776805 |
ERBB2
|
Health Risk |
Pathogenic |
Lung adenocarcinoma, Lung adenocarcinoma |
| RS587776806 |
NPM1
|
Health Risk |
Pathogenic |
Acute myeloid leukemia, Myelodysplastic syndrome progressed to acute myeloid leukemia |
| RS587776807 |
IL12B
|
Health Risk |
Pathogenic |
Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency, Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency |
| RS587776808 |
MYH9
|
Health Risk |
Pathogenic |
Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss |
| RS587776809 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 |
| RS587776810 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS587776811 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS587776812 |
LAMB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Junctional epidermolysis bullosa, non-Herlitz type |
| RS587776813 |
LAMB3
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa, non-Herlitz type |
| RS587776814 |
LAMB3
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa, non-Herlitz type |
| RS587776815 |
KRT10
|
Health Risk |
Pathogenic |
Congenital reticular ichthyosiform erythroderma, Congenital reticular ichthyosiform erythroderma |
| RS587776816 |
KRT10
|
Health Risk |
Pathogenic |
Congenital reticular ichthyosiform erythroderma, Congenital reticular ichthyosiform erythroderma |
| RS587776817 |
KRT10
|
Health Risk |
Pathogenic |
Congenital reticular ichthyosiform erythroderma, Congenital reticular ichthyosiform erythroderma |
| RS587776819 |
INSR
|
Health Risk |
Pathogenic |
Rabson-Mendenhall syndrome, Rabson-Mendenhall syndrome |
| RS587776820 |
INSR
|
Health Risk |
Pathogenic |
Rabson-Mendenhall syndrome, Rabson-Mendenhall syndrome |
| RS587776822 |
IFNGR2
|
Health Risk |
Pathogenic |
Immunodeficiency 28, Immunodeficiency 28 |
| RS587776823 |
IFNGR2
|
Health Risk |
Pathogenic |
Immunodeficiency 28, Immunodeficiency 28 |
| RS587776825 |
HNF1A
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young type 3, Clear cell carcinoma of kidney |
| RS587776826 |
HBA2
|
Health Risk |
Pathogenic |
Alpha trait thalassemia, Alpha trait thalassemia |
| RS587776827 |
HBA2
|
Health Risk |
Likely pathogenic |
HEMOGLOBIN CLINICO-MADRID, Hemoglobin H disease |
| RS587776828 |
HBA2
|
Health Risk |
Pathogenic |
Alpha-thalassemia, Hmong type |
| RS587776829 |
GNAS
|
Health Risk |
Pathogenic/Likely pathogenic |
Pseudohypoparathyroidism, Progressive osseous heteroplasia |
| RS587776831 |
GYS2
|
Health Risk |
Pathogenic |
Glycogen storage disorder due to hepatic glycogen synthase deficiency, Glycogen storage disorder due to hepatic glycogen synthase deficiency |